Targeted delivery of an ADP-ribosylating bacterial toxin into cancer cells

Scientific Reports

Volumn 7, Issue , 2017, Pages

  Zahaf, N I ^a   Lang, A E ^a   Kaiser, L ^a   Fichter, C D ^b,c   Lassmann, S ^a,b,c,d   McCluskey, A ^e   Augspach, A ^a   Aktories, K ^a,c   Schmidt, G ^a,c  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c UNIVERSITY OF FREIBURG   (Germany)

^d German Consortium for Translational Cancer Research (DKTK)   (Germany)

^e HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRAX TOXIN; BACTERIAL ANTIGEN; BACTERIAL TOXIN; EGFR PROTEIN, HUMAN; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ERBB2 PROTEIN, HUMAN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE;

ACTIN FILAMENT; ADENOSINE DIPHOSPHATE RIBOSYLATION; CHEMISTRY; DRUG EFFECT; ESOPHAGUS TUMOR; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MICROBIOLOGY; PATHOLOGY; PHOTORHABDUS; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE;

ACTIN CYTOSKELETON; ADP RIBOSE TRANSFERASES; ADP-RIBOSYLATION; ANTIGENS, BACTERIAL; BACTERIAL TOXINS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; ESOPHAGEAL NEOPLASMS; GENE EXPRESSION REGULATION; HUMANS; PHOTORHABDUS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2;

EID: 85010955862     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep41252     Document Type: Article

References (35)

1. Pastan, I., Hassan, R., FitzGerald, D. J., Kreitman, R. J. Immunotoxin therapy of cancer. Nat. Rev. Cancer 6, 559-565 (2006).
2. Kreitman, R. J. Immunotoxins in cancer therapy. Curr. Opin. Immunol 11, 570-578 (1999).
3. Antignani, A., Fitzgerald, D. Immunotoxins: the role of the toxin. Toxins (Basel) 5, 1486-1502 (2013).
4. Kreitman, R. J. Recombinant immunotoxins containing truncated bacterial toxins for the treatment of hematologic malignancies. BioDrugs 23, 1-13 (2009).
5. Barth, H. et al. Low pH-induced formation of ion channels by Clostridium difficile toxin B in target cells. J. Biol. Chem 276, 10670-10676 (2001).
6. Pfeifer, G. et al. Cellular uptake of Clostridium difficile toxin B: translocation of the N-terminal catalytic domain into the cytosol of eukaryotic cells. J. Biol. Chem 278, 44535-44541 (2003).
7. Blumenthal, B., Hoffmann, C., Aktories, K., Backert, S., Schmidt, G. The Cytotoxic Necrotizing Factors from Yersinia pseudotuberculosis and from Escherichia coli Bind to Different Cellular Receptors but Take the Same Route to the Cytosol. Infect. Immun 75, 3344-3353 (2007).
8. Weldon, J. E., Pastan, I. A guide to taming a toxin-recombinant immunotoxins constructed from Pseudomonas exotoxin A for the treatment of cancer. FEBS J 278, 4683-4700 (2011).
9. Wayne, A. S., Fitzgerald, D. J., Kreitman, R. J., Pastan, I. Immunotoxins for leukemia. Blood 123, 2470-2477 (2014).
10. Morimoto, H., Bonavida, B. Diphtheria toxin-and Pseudomonas A toxin-mediated apoptosis. ADP ribosylation of elongation factor-2 is required for DNA fragmentation and cell lysis and synergy with tumor necrosis factor-alpha. J. Immunol 149, 2089-2094 (1992).
11. Figgitt, D. P., Lamb, H. M., Goa, K. L. Denileukin diftitox. Am. J. Clin. Dermatol 1, 67-72 (2000).
12. Fuentes, A. C. et al. Denileukin Diftitox (Ontak) as Maintenance Therapy for Peripheral T-Cell Lymphomas: Three Cases with Sustained Remission. Case. Rep. Oncol. Med 2015, 123756 (2015).
13. Barth, H., Roebling, R., Fritz, M., Aktories, K. The binary Clostridium botulinum C2 toxin as a protein delivery system: identification of the minimal protein region necessary for interaction of toxin components. J. Biol. Chem 277, 5074-5081 (2002).
14. Aktories, K., Barth, H. The actin-ADP-ribosylating Clostridium botulinum C2 toxin. Anaerobe 10, 101-105 (2004).
15. Bradley, K. A., Mogridge, J., Mourez, M., Collier, R. J., Young, J. A. Identification of the cellular receptor for anthrax toxin. Nature 414, 225-229 (2001).
16. Basilio, D., Juris, S. J., Collier, R. J., Finkelstein, A. Evidence for a proton-protein symport mechanism in the anthrax toxin channel. J. Gen. Physiol 133, 307-314 (2009).
17. Leppla, S. H. In Bacterial toxins and virulence factors in disease Handbook of natural toxins (eds J. Moss, B. Iglewski, M. Vaughan & A. T. Tu) 543-572 (Marcel Dekker, 1995).
18. Klimpel, K. R., Molloy, S. S., Thomas, G., Leppla, S. H. Anthrax toxin protective antigen is activated by a cell surface protease with the sequence specificity and catalytic properties of furin. Proc. Natl. Acad. Sci. USA 89, 10277-10281 (1992).
19. Liu, S., Netzel-Arnett, S., Birkedal-Hansen, H., Leppla, S. H. Tumor cell-selective cytotoxicity of matrix metalloproteinaseactivated anthrax toxin. Cancer Res 60, 6061-6067 (2000).
20. Collier, R. J. Membrane translocation by anthrax toxin. Mol. Aspects Med 30, 413-422 (2009).
21. Valderrama, F. et al. Actin microfilaments facilitate the retrograde transport from the Golgi complex to the endoplasmic reticulum in mammalian cells. Traffic 2, 717-726 (2001).
22. Ballard, J. D., Collier, R. J., Starnbach, M. N. Anthrax toxin-mediated delivery of a cytotoxic T-cell epitope in vivo. Proc. Natl. Acad. Sci. USA 93, 12531-12534 (1996).
23. McCluskey, A. J., Olive, A. J., Starnbach, M. N., Collier, R. J. Targeting HER2-positive cancer cells with receptor-redirected anthrax protective antigen. Mol. Oncol (2012).
24. Mechaly, A., McCluskey, A. J., Collier, R. J. Changing the receptor specificity of anthrax toxin. MBio 3 (2012).
25. Lang, A. E. et al. Actin ADP-ribosylation at Threonine148 by Photorhabdus luminescens toxin TccC3 induces aggregation of intracellular F-actin. Cell Microbiol (2016).
26. Aktories, K., Schmidt, G., Lang, A. E. Photorhabdus luminescens toxins TccC3 and TccC5: insecticidal ADP-ribosyltransferases that modify threonine and glutamine. Curr. Top. Microbiol. Immunol 384, 53-67 (2015).
27. Fichter, C. D. et al. ErbB targeting inhibitors repress cell migration of esophageal squamous cell carcinoma and adenocarcinoma cells by distinct signaling pathways. J. Mol. Med. (Berl) (2014).
28. Sheets, J. J. et al. Insecticidal toxin complex proteins from Xenorhabdus nematophilus: structure and pore formation. J. Biol. Chem 286, 22742-22749 (2011).
29. Lang, A. E. et al. Photorhabdus luminescens toxins ADP-ribosylate actin and RhoA to force actin clustering. Science 327, 1139-1142 (2010).
30. Meusch, D. et al. Mechanism of Tc toxin action revealed in molecular detail. Nature 508, 61-65 (2014).
31. Sun, J., Lang, A. E., Aktories, K., Collier, R. J. Phenylalanine-427 of anthrax protective antigen functions in both pore formation and protein translocation. Proc. Natl. Acad. Sci. USA 105, 4346-4351 (2008).
32. Schmidt, G., Papatheodorou, P., Aktories, K. Novel receptors for bacterial protein toxins. Curr. Opin. Microbiol 23C, 55-61 (2015).
33. Collier, R. J., Young, J. A. Anthrax toxin. Annu. Rev. Cell Dev. Biol 19, 45-70 (2003).
34. Mannherz, H. G., Hannappel, E. The beta-thymosins: intracellular and extracellular activities of a versatile actin binding protein family. Cell Motil. Cytoskeleton 66, 839-851 (2009).
35. Bachran, C., Leppla, S. H. Tumor Targeting and Drug Delivery by Anthrax Toxin. Toxins (Basel) 8 (2016).